Advanced search

Mathieu Lamy occupies the position of Chief Operating Officer & Executive Vice President at Intact Financial Corp. He is also Senior Vice President-Claims at Claims At Intact Insurance. He previously was Chief Information Officer & Senior Vice President for IntAct Labs LLC, Executive Vice President-Operations for AXA Life Insurance (Canada) and Executive Vice President of AXA Canada, Inc. Mr. Lamy received an undergraduate degree from Université Laval.

Currently, Mathieu Vrijsen occupies the position of Chairman-Supervisory Board at Casco Phil, Chairman-Supervisory Board for Broadview Holding BV and Chairman-Supervisory Board of Corbion NV. Mr. Vrijsen is also on the board of Swiss-American Chamber of Commerce, The European Association for Bioindustries, Desso BV and Joma Sport BVBA and Member-Executive Committee at International Institute for Management Development. In his past career he held the position of Senior Vice President-Operations & Engineering at E.I. du Pont de Nemours & Co.

Mr. Mathieu Bonnet is a Chairman at E6 SAS, a Chief Executive Officer & Director at Allego BV, a Chief Executive Officer & Director at Allego NV, a Chief Executive Officer at Allego BV (New) and a President at Spartan Acquisition Corp.
III.
He is on the Board of Directors at Allego BV and Allego NV.
Mr. Bonnet was previously employed as a Chief Executive Officer by Compagnie Nationale du Rhône.
He received his undergraduate degree from Ecole Polytechnique, a graduate degree from École Nationale Supérieure des Mines de Paris and a graduate degree from Université Catholique de Louvain.

Dr. Mathieu Simon is a Chairman at Epsilen Bio SRL, a Chairman at Idorsia Ltd., an Independent Director at Asarina Pharma AB, an Independent Director at Vaximm AG, a Chairman at Idorsia Pharmaceuticals Ltd., a Chief Executive Officer at Cellectis Therapeutics and an Independent Director at LNC Therapeutics SA. He is on the Board of Directors at Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associés SCA and LNC Therapeutics SA. Dr. Simon was previously employed as an EVP, Chief Operating & Medical Officer by Cellectis SA, a Vice President-Marketing & Medical Affairs by Wyeth Pharmaceuticals LLC, a Group VP-Marketing & Clinical Affairs by Wyeth-Ayerst International, Inc., a Senior Vice President-Global Operations by Pierre Fabre Médicament SAS, a Managing Director & Head-Global Pharma by Pierre Fabre SA, and a Chairman & Chief Executive Officer by Takara Bio Europe AB. He also served on the board at Alliance for Regenerative Medicine, Ectycell SASU and Farmindustria.

Mathieu Bernard Streiff is the founder of American Healthcare Investors LLC, which was founded in 2011.
He held the title of General Counsel & Managing Director at the firm from 2011 to 2019.
Mr. Streiff's current jobs include being a Director at Hawkhill House Ltd.
since 2016, a Director at American Healthcare REIT, Inc. since 2015, a Director at GAHC3 U.K.
Senior Care Holding Ltd., a Director at Coniston Care Centre Ltd.
since 2016, a Director at Orchard St Albans Housing Portfolio Ltd.
since 2015, a Member of the New York State Bar Association, an Executive Vice President at Griffin-American Healthcare REIT Sub-Advisor, LLC since 2012, and an Executive Vice President at Griffin-American Healthcare REIT III Advisor LLC since 2012.
Mr. Streiff's former jobs include being a Director at Trilogy Investors LLC, Executive Vice President & General Counsel at Grubb & Ellis Co. from 2010 to 2011, Executive Vice President & General Counsel at Griffin-American Healthcare REIT II, Inc. from 2012 to 2014, Executive Vice President & General Counsel at Griffin-American Healthcare REIT III, Inc. from 2013 to 2021, an Associate at Latham & Watkins LLP from 2002 to 2006, Secretary, Executive VP & General Counsel at Grubb & Ellis Realty Investors LLC in 2011, and Executive Vice President at Griffin American Healthcare Reit Advisor LLC from 2011 to 2014.
Mr. Streiff's education includes an undergraduate degree from the University of California, Berkeley and a graduate degree from Columbia Law School.

Mr. Mathieu O. Floreani is a Chairman-Management Board & CEO at Synlab AG, a Co-Managing Director at LS Medizin Service GmbH, a Group Chief Executive Officer at SYNLAB International GmbH and a Co-Managing Director at Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH. He is on the Board of Directors at Synlab Diagnósticos Globales SA, ALcontrol Group Ltd., Labco UK Group Ltd. and SYNLAB Ltd. Mr. Floreani was previously employed as a President, Chief Executive Officer & Director by DHL Global Forwarding North America and a Managing Director by SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH.

Hubert Lamy has a current job as a Director at ATIC Services SAS.

Olivier Lamy is currently a Director at Pobi Industrie SA, Pobi Charpentes SA, Perform Habitat SAS, La Barrade SNC, and AST Services SAS.
He previously worked as a Director-Administrative & Finance at A.S.T.
Groupe SA from 2013 to 2016 and as a Senior Manager at Arthur Andersen & Cia from 2001 to 2002.
Mr. Lamy obtained his undergraduate degree from ESCP Europe Campus Paris in 1998 and Burgundy School of Business in 1998.

Alina Lamy is a Senior Analyst at Morningstar, Inc. (Research).
She completed her undergraduate degree at Illinois Institute of Technology.

Donzé Aurélia Lamy worked as a Portfolio Manager at Edmond de Rothschild Asset Management (Suisse) SA from 2009 to 2015.

Guillaume Lamy currently works at Menguy's SA, as Co-Chief Executive Officer, Les Fromageries Occitanes SAS, as Marketing Director, and Sphere Production SA, as Managing Director.

Mr. Arnaud-Guilhem Lamy is a Head of Euro Aggregate Bond Management Strategies at BNP Paribas Asset Management Europe SAS.
He is responsible for euro-aggregate's bond management strategies and is also an expert in socially responsible investment (SRI) for bond management.
Prior to joining BNP Paribas Asset Management in 2010, he was Eurobond Portfolio Manager at Fortis Investments in London (2007-2010), responsible for ABS and covered bonds.
He was a credit analyst at Société Générale Asset Management (2005-2007), after starting his career at Crédit Foncier de France in 2001 as a securitisation specialist.
He graduated in Finance and Economics from the Ecole Nationale de la Statistique et de l'Administration Economique (ENSAE, France, 2001).
He also holds a Master's degree in Applied Mathematics from Dauphine University (Paris, France, 1999).

Caroline Lamy is currently working as the Co-Head of Equity Management at Crédit Mutuel Asset Management SA since 2021.
Previously, she worked as an Analyst at ING Belgium SA (France) in 2001.

Marc Lamy has held positions as an Independent Non-Executive Director at Alliances Developpement Immobilier SA and as a Founding Member at Institut Français Des Administrateurs.

Daryl Lamy worked as a General Manager-Business Development at Sundyne LLC from 1988 to 2017.
Prior to that, he worked as a Principal at Goulds Pumps LLC.
He received his undergraduate degree and MBA from Louisiana State University.

Veronique Lamy has worked as the Director of Human Resources at Eurogerm SA since 1989.

Guy-François Lamy has worked as a Director at Canadian Employers Council and as an Associate at Stikeman Elliott LLP.

Thomas Lamy is the founder of Biosynex SA, founded in 2005, where he holds the title of Director & Vice President.
He was also the founder of Dectra Pharm SAS, founded in 2005, where he held the title of Chief Executive Officer.
Additionally, he is the founder of All.
Diag SAS, founded in 1993, where he held the title of Chairman & Managing Director until 2015.
Dr. Lamy's current job(s) include being the Chief Executive Officer & Director at Biosynex Swiss SA, Chief Executive Officer & Director at Biosynex Premier SA, Chairman at A.J.T.
Financière SAS, and Sales Manager at PBS Orgenics.
Dr. Lamy's former job(s) include being a Director at Theradiag SA in 2022.
Dr. Lamy's education history includes an MBA from École des Hautes Études Commerciales de Paris and a doctorate from Institut National Polytechnique de Lorraine, conferred in 1986.

Christophe Lamy has been the General Manager at Envea SA since 2001.

Tiphanie Lamy is currently the Deputy Managing Director at FLCP & Associés SASU and FLCP & Associes Invest SAS.
She is also a Member-Supervisory Board at Focus Entertainment SA. Previously, she worked as a Director at Tuvalu Media Netherlands BV.

Emilie Lamy has worked as a Director at Prestige Motor Holdings SA since 2015.

Mr. David Lamy is Head-Technology & Architecture at Levels Beyond, Inc. Mr. Lamy was previously employed as Application Developer by NCR Corp., Developer by OppenheimerFunds, Inc., Development Team Lead by ADTRAN, Inc., a Principal by Globus & Cosmos Travel, and Senior Developer by MarketVision, Inc.

Laurence Lamy currently works as a Manager of Corporate Communications at Mersen SA.

Yasemin Lamy joined British International Investment as Deputy CIO in August 2018.
She is responsible for the Catalyst Strategies, a portfolio aimed at transformational, system-level impact and innovation across its target geographies of Africa and South Asia.
Prior to British International Investment, she spent three years building two new portfolios for Omidyar Network: one portfolio to develop empowering digital identity technologies and one portfolio to establish a trendspotting capability.
Previously, she worked across several different roles within capital markets at J.P.
Morgan, starting out in fund-linked derivatives and then as a credit derivatives analyst, before building and leading the impact investment platform for the firm.
Yasemin has published widely and provided expert advice to the OECD, World Economic Forum and others.
She holds a Masters in Financial Mathematics from King’s College, London and a Bachelor in Mathematics and Philosophy from the University of Pennsylvania.

Pascal Lamy is currently the Director at Thomson Reuters Founders Share Co., Ltd., the Director at Centre on Regulation in Europe, a Professor at China Europe International Business School, and the President-Emeritus at Jacques Delors Institute.
He was formerly the Director General at the World Trade Organization.

Marc Lamy is currently a Director at Devolutions, Inc. He previously held positions as President, CEO, CFO & Director at Mindready Solutions, Inc., Director at LYRtech, Inc., Director at Accovia, Inc., Director at 9070-9759 Québec, Inc., Principal at Deloitte & Touche LLP, Chief Financial Officer at iBwave Solutions, Inc., and Chief Financial Officer at CrowdCare Corp.
He received both undergraduate and graduate degrees from the University of Montréal.

Richard B.
Lamy worked as Vice President for Major Accounts at MICROS Systems, Inc. He was also a Manager for District Sales at NCR Voyix Corp.
and Vice President for Sales at Exit41, Inc. and Savista Corp.
Additionally, he served as Chief Revenue Officer at Zipscene LLC and Vice President for Sales at Retail DNA, Inc. Lamy obtained an undergraduate degree from Providence College.

Maxim Saint-Amant Lamy worked as the Chief Compliance Officer & Operations Manager at Nymbus Capital, Inc. from 2019 to 2020.
He received his undergraduate and graduate degrees from HEC Montréal.

Elaine M.
Lamy currently works as a Development Director at Engaging Schools, Inc.

Daniel Lamy currently works at JPMorgan Securities Plc, as Strategist from 2004.

Mr. Gérard Lamy is a Director-Research at Wendel SA and a Member at The French Society of Financial Analysts.
He received his undergraduate degree from École des Hautes Études Commerciales de Paris.

Jean-Lucien Lamy is currently the Chief Executive Officer at FCI USA LLC.
Prior to this, he worked as a Director at Aliaxis SA.

François Lamy currently works as a Director for the Association Française contre les Myopathies.

Bertrand Lamy currently works as a Co-Managing Director at Cab Selarl.

Didier Lamy has been the Chairman-Supervisory board of JL Bourg Basket SASP since 2008.

Kenneth S.
Lamy is the founder of The Lamy Group Ltd.
He is currently working as a Director at the National Association of Real Estate Cos.